comparemela.com

Shandong Boan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Another Chinese billionaire to emerge as Tencent-backed robot maker UBTech makes final Hong Kong IPO of 2023

UBTech, a Chinese maker of robots, will make its Hong Kong listing debut on the final trading day of 2023. Its 47-year old founder and CEO Zhou Jian is set to become a billionaire.

Hong Kong ends 2022 with five listings, ending a tough year with a bang as IPOs trickle back

The HK$394 million raised by three of the five companies are a much-needed boost for Hong Kong as it clings to fourth place behind Shanghai, Shenzhen and Seoul among the world’s top IPO destinations.

Bevacizumab Biosimilar Demonstrates Positive Phase 3 Results for the Treatment of Non-Small Cell Lung Cancer | Goodwin

A study recently published in Cancer Communications reported that LY01008 or BOYOUNUO, a bevacizumab biosimilar developed by Shandong Boan Biotechnology Co., Ltd. (“Shandong Boan”), a.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.